Oligonucleotide therapy: An emerging focus area for drug delivery in chronic inflammatory respiratory diseases

M Mehta, D Tewari, G Gupta, R Awasthi, H Singh… - Chemico-biological …, 2019 - Elsevier
Oligonucleotide-based therapies are advanced novel interventions used in the management
of various respiratory diseases such as asthma and Chronic Obstructive Pulmonary Disease …

Designing biomaterials with immunomodulatory properties for tissue engineering and regenerative medicine

JI Andorko, CM Jewell - Bioengineering & translational …, 2017 - Wiley Online Library
Recent research in the vaccine and immunotherapy fields has revealed that biomaterials
have the ability to activate immune pathways, even in the absence of other immune …

Peptide/protein vaccine delivery system based on PLGA particles

M Allahyari, E Mohit - Human vaccines & immunotherapeutics, 2016 - Taylor & Francis
abstract Due to the excellent safety profile of poly (D, L-lactide-co-glycolide)(PLGA) particles
in human, and their biodegradability, many studies have focused on the application of PLGA …

Nanovaccine‐based strategies to overcome challenges in the whole vaccination cascade for tumor immunotherapy

L Qin, H Zhang, Y Zhou, CS Umeshappa, H Gao - Small, 2021 - Wiley Online Library
Nanovaccine‐based immunotherapy (NBI) has received greater attention recently for its
potential to prime tumor‐specific immunity and establish a long‐term immune memory that …

Recent applications and strategies in nanotechnology for lung diseases

W Zhong, X Zhang, Y Zeng, D Lin, J Wu - Nano Research, 2021 - Springer
Lung diseases, including COVID-19 and lung cancers, is a huge threat to human health.
However, for the treatment and diagnosis of various lung diseases, such as pneumonia …

CpG oligodeoxynucleotide nanomedicines for the prophylaxis or treatment of cancers, infectious diseases, and allergies

N Hanagata - International journal of nanomedicine, 2017 - Taylor & Francis
Unmethylated cytosine-guanine dinucleotide-containing oligodeoxynucleotides (CpG
ODNs), which are synthetic agonists of Toll-like receptor 9 (TLR9), activate humoral and …

PLGA particles in immunotherapy

D Horvath, M Basler - Pharmaceutics, 2023 - mdpi.com
Poly (lactic-co-glycolic acid)(PLGA) particles are a widely used and extensively studied drug
delivery system. The favorable properties of PLGA such as good bioavailability, controlled …

Inhaled drug delivery for the targeted treatment of asthma

A Boboltz, S Kumar, GA Duncan - Advanced Drug Delivery Reviews, 2023 - Elsevier
Asthma is a chronic lung disease affecting millions worldwide. While classically
acknowledged to result from allergen-driven type 2 inflammatory responses leading to IgE …

Nanoparticle-based delivery of CRISPR/Cas9 genome-editing therapeutics

BE Givens, YW Naguib, SM Geary, EJ Devor… - The AAPS journal, 2018 - Springer
The recent progress in harnessing the efficient and precise method of DNA editing provided
by CRISPR/Cas9 is one of the most promising major advances in the field of gene therapy …

Acidic pH-responsive polymer nanoparticles as a TLR7/8 agonist delivery platform for cancer immunotherapy

H Kim, D Sehgal, TA Kucaba, DM Ferguson, TS Griffith… - Nanoscale, 2018 - pubs.rsc.org
Synthetic imidazoquinoline-based toll-like receptor (TLR) 7/8 bi-specific agonists are
promising vaccine adjuvants that can induce maturation of dendritic cells (DCs) and activate …